Clinical study of an Ayurvedic capsule in fungal infection

Clinical evaluation of Finbid Capsule in the management of Sidhma Kushtha w.s.r. to Fungal Infection including Candidiasis and Dermatophytosis.

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/03/023905

Enrollment

Registered

2020-03-12

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue

Interventions

Intervention1: Finbid Capsule: Finbid Capsule Dose- 2 Capsule twice a day orally after meal. Duration- 60 days Control Intervention1: Nil: Nil

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients willing for trial. 2. The patients in the age group of 18â?? 60 years. 3. The patients having clinical signs and symptoms of Sidhma kushtha & Fungal dermatophytosis. 4. Patient with positive KOH test for Fungal dermatophytosis 5. The patients with duration of symptoms less than 5 year duration.

Exclusion criteria

Exclusion criteria: 1. Patients with long term history of steroid and cytotoxic treatment. 2. Patients having concomitant illness like HTN, Type-2DM etc. 3. Patients with evidence of malignancy. 4. Pregnant or lactating women.

Design outcomes

Primary

Measure	Time frame
Changes in the clinical symptoms of Sidhma KushthaTimepoint: two months	—

Secondary

Measure	Time frame
Change in the objective parametersTimepoint: 2 months	—

Countries

India

Contacts

Public ContactDr Harish Bhakuni

National Institute of Ayurveda Jaipur

drsan_agr@yahoo.com9887644272

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026